Improving HIV testing and prevention in Sub-Saharan Africa using rapid tests.
Rapid Tests for Recent Infection (RTRI) for Precision Public Health in Sub-Saharan Africa: Next-Generation Strategies Amid Changing HIV Epidemiology
This study is looking at how quick tests for recent HIV infections can help improve testing and prevention efforts in Sub-Saharan Africa, making sure that support and resources go to those who need it most.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10977062 on NIH RePORTER |
What this research studies
This research focuses on enhancing HIV testing and prevention strategies in Sub-Saharan Africa by utilizing rapid tests for recent HIV infections. These tests can quickly identify individuals who have been recently infected, allowing for targeted public health responses. By implementing a precision public health approach, the research aims to improve the efficiency of HIV services, ensuring that resources are allocated where they can have the greatest impact. The study will analyze the effectiveness of these rapid tests in real-time to better control the HIV epidemic in the region.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals aged 21 and older living in Sub-Saharan Africa who may be at risk for HIV infection.
Not a fit: Patients who are not at risk for HIV infection or who are already receiving effective treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective HIV prevention and testing strategies, ultimately reducing new infections in Sub-Saharan Africa.
How similar studies have performed: Other research has shown promise in using rapid tests for recent infections, indicating that this approach could be effective in improving HIV response strategies.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Bershteyn, Anna — New York University School of Medicine
- Study coordinator: Bershteyn, Anna
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.